Pliant Therapeutics (PLRX) PT Raised to $48 at JPMorgan
Tweet
Share
E-mailGet Alerts PLRX Hot Sheet
Price: $1.07 -0.93%
Rating Summary:
4 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
4 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
JPMorgan analyst Eric Joseph raised the price target on Pliant Therapeutics (NASDAQ: PLRX) to $48.00 (from $47.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Pliant Therapeutics, Inc. (PLRX) Misses Q2 EPS by 2c
- GMR Airports Infrastructure (GMRI:IN) PT Raised to INR99 at ICICI Securities
- Indigo Paints (INDIGOPN:IN) PT Raised to INR1,300 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
